Company research
Hinge Health, Inc.
CIK 1673743Updated Sep 26, 2026
SecurityHNGE · NYSE · equity
HNGE price & chart
Loading TradingView…
NYSE:HNGE on TradingView ↗About the company
We are a leading technology platform for individuals seeking to treat and prevent joint and muscle pain. We leverage technology and AI to automate and scale a care plan designed and monitored by our care team, while delivering improved member outcomes, personalized member experiences, and cost reductions for our clients.
In the news
NYSE Content Advisory: Pre-Market update + Hinge Health, MNTN pop double digits in trading debuts USA - English APAC - English News provided by New York Stock Exchange May 23, 2025, 08:55 ET Share this article Share to X Share this article Share to X NEW YORK , May 23, 2025 /PRNewswire/ -- The New Y ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 |
|---|---|---|
| ASSETS | ||
| AssetsUSD | 744,761,000Source | 673,259,000Source |
| Property, Plant and Equipment, NetUSD | 10,490,000Source | 7,380,000Source |
| GoodwillUSD | 64,096,000Source | 61,607,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 2,512,000Source | 1,807,000Source |
| Current assets: | ||
| Cash and Cash Equivalents, at Carrying ValueUSD | 207,995,000Source | 300,785,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 66,061,000Source | 42,495,000Source |
| Inventory, NetUSD | 15,636,000Source | 10,873,000Source |
| Assets, CurrentUSD | 533,904,000Source | 583,446,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 57,001,000Source | 44,891,000Source |
| Operating Lease, Right-of-Use AssetUSD | 6,861,000Source | 9,607,000Source |
| Other Assets, NoncurrentUSD | 13,726,000Source | 9,412,000Source |
| LIABILITIES AND EQUITY | ||
| LiabilitiesUSD | 366,225,000Source | 256,557,000Source |
| Stockholders’ equity: | ||
| Common Stock, Value, IssuedUSD | — | 0Source |
| Additional Paid in CapitalUSD | 1,229,678,000Source | 88,097,000Source |
| Retained Earnings (Accumulated Deficit)USD | -1,050,996,000Source | -522,735,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -20,000Source | 68,000Source |
| Stockholders' Equity Attributable to ParentUSD | 178,662,000Source | -434,570,000Source |
| Liabilities and EquityUSD | 744,761,000Source | 673,259,000Source |
| Current liabilities: | ||
| Liabilities, CurrentUSD | 362,409,000Source | 249,299,000Source |
| Operating Lease, Liability, CurrentUSD | 4,223,000Source | 3,814,000Source |
| Operating Lease, Liability, NoncurrentUSD | 3,816,000Source | 7,258,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 |
|---|---|---|
| Cash flows from operating activities: | ||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 643,009,000Source | 739,000Source |
| Changes in operating assets and liabilities: | ||
| Increase (Decrease) in Accounts ReceivableUSD | 26,627,000Source | 1,340,000Source |
| Increase (Decrease) in InventoriesUSD | 4,763,000Source | -608,000Source |
| Deferred Income Tax Expense (Benefit)USD | 53,000Source | -585,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 171,441,000Source | 49,002,000Source |
| Cash flows from investing activities: | ||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -113,763,000Source | 18,312,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 708,000Source | 1,039,000Source |
| Cash flows from financing activities: | ||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 295,229,000Source | 0Source |
| Payments for Repurchase of Common StockUSD | 65,028,000Source | 0Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -150,468,000Source | -2,202,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 209,796,000Source | 302,586,000Source |
| Supplemental disclosure of cash flow information: | ||
| Income Taxes Paid, NetUSD | 1,556,000Source | 0Source |
| Additional Financial Items | ||
| Share-based Payment Arrangement, ExpenseUSD | 643,009,000Source | 739,000Source |
| Amortization of Intangible AssetsUSD | 900,000Source | 400,000Source |
| Capitalized Computer Software, AmortizationUSD | 3,000,000Source | 3,600,000Source |
| DepreciationUSD | 1,300,000Source | 2,000,000Source |
| General and Administrative ExpenseUSD | 329,505,000Source | 63,915,000Source |
| GoodwillUSD | 64,096,000Source | 61,607,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | 998,000Source | 677,000Source |
| Inventory Write-downUSD | 0Source | 1,812,000Source |
| Net Income (Loss) Attributable to ParentUSD | -528,261,000Source | -11,933,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -424,087,000Source | -11,933,000Source |
| Nonoperating Income (Expense)USD | 19,108,000Source | 20,654,000Source |
| Operating ExpensesUSD | 1,014,593,000Source | 331,812,000Source |
| Operating Lease, ExpenseUSD | 3,431,000Source | 3,649,000Source |
| Proceeds from Issuance of Common StockUSD | 8,113,000Source | 0Source |
| Proceeds from Stock Options ExercisedUSD | 1,416,000Source | 610,000Source |
| Provision for Loan, Lease, and Other LossesUSD | 3,061,000Source | 5,410,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 |
|---|---|---|
| Total RevenueUSD | 587,860,000Source | 390,404,000Source |
| Cost of Goods and Services Sold | — | — |
| Operating Income (Loss)USD | -546,371,000Source | -31,910,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -527,263,000Source | -11,256,000Source |
| Income Tax Expense (Benefit)USD | 998,000Source | 677,000Source |
| Net Income (Loss) Attributable to ParentUSD | -528,261,000Source | -11,933,000Source |
| Earnings Per Share, BasicUSD per share | -7.77Source | -0.88Source |
| Earnings Per Share, DilutedUSD per share | -7.77Source | -0.88Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 54,577,000Source | 13,558,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 54,577,000Source | 13,558,000Source |
| Additional Financial Items | ||
| Amortization of Intangible AssetsUSD | 900,000Source | 400,000Source |
| Capitalized Computer Software, AmortizationUSD | 3,000,000Source | 3,600,000Source |
| Current Income Tax Expense (Benefit)USD | 945,000Source | 1,262,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 5,133,000Source | 5,950,000Source |
| General and Administrative ExpenseUSD | 329,505,000Source | 63,915,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source |
| Gross ProfitUSD | 468,222,000Source | 299,902,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -529,840,000Source | -12,396,000Source |
| Interest and Other IncomeUSD | 18,683,000Source | 20,572,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -424,087,000Source | -11,933,000Source |
| Nonoperating Income (Expense)USD | 19,108,000Source | 20,654,000Source |
| Operating ExpensesUSD | 1,014,593,000Source | 331,812,000Source |
| Operating Lease, ExpenseUSD | 3,431,000Source | 3,649,000Source |
| Research and Development ExpenseUSD | 368,137,000Source | 100,839,000Source |
| Selling and Marketing ExpenseUSD | 316,951,000Source | 167,058,000Source |
Offerings
Registration 333-285682
- Gross proceeds
- 437312000.0
- Net proceeds
- 255675840.0
- Deal price
- 32.0
- Shares
- 13666000
- Offering amount
- $437,312,000
- Offering price
- $32.00
- Ticker
- HNGE
Filing attachments
hnge-q2202684xex991.htm · 8-K · 2026-08-04
EX-99.1 2 hnge-q2202684xex991.htm EX-99.1 Document Exhibit 99.1 Hinge Health reports record second quarter 2026 financial results; signs definitive agreement to acquire Cylinder Health • Signed a definitive agreement to acquire Cylinder Health, Inc., expanding into gastrointestinal care • Revenue increased 53% year-over-year to $213 million • Free cash flow of $100 million, up 3x year-over-year • 2026 revenue guidance midpoint raised to $858 million, reflecting 46% year-over-year growt…
Read attachment ↗hnge-q2202684xex992.htm · 8-K · 2026-08-04
EX-99.2 3 hnge-q2202684xex992.htm EX-99.2 Document Exhibit 99.2 Hinge Health to acquire Cylinder Health, expanding into gastrointestinal care The acquisition accelerates Hinge Health’s entry into one of healthcare’s largest underserved categories, with an integrated Gastrointestinal Care Program expected to launch in 2027. San Francisco, CA - August 4, 2026 - Hinge Health, Inc. (NYSE: HNGE) today announced that it has signed a definitive agreement to acquire Cylinder Health, Inc, a leade…
Read attachment ↗hnge-202669ex991.htm · 8-K · 2026-06-09
EX-99.1 2 hnge-202669ex991.htm EX-99.1 Document Exhibit 99.1 Hinge Health hosts its first Investor Day and raises guidance ● Full year 2026 revenue guidance raised to a range of $818 million to $824 million, up $20 million at the midpoint from its prior range and marking 40% year-over-year growth ● Full year 2026 non-GAAP operating margin of 27% now expected at the midpoint San Francisco, CA - June 9, 2026 - Tomorrow, June 10, Hinge Health, Inc. (NYSE: HNGE) will host its inaugural Inve…
Read attachment ↗hnge-q1202655xex991.htm · 8-K · 2026-05-05
EX-99.1 2 hnge-q1202655xex991.htm EX-99.1 Document Exhibit 99.1 Hinge Health reports record first quarter 2026 financial results San Francisco, California - May 5, 2026 - Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the first quarter ended March 31, 2026. “We generated $182 million in revenue this quarter with 47% year-over-year growth, well ahead of expectations, driven by the strength of a platform that automates care delivery, improves member outcomes and lowe…
Read attachment ↗hnge-2026210xex991.htm · 8-K · 2026-02-10
EX-99.1 2 hnge-2026210xex991.htm EX-99.1 Document Exhibit 99.1 Hinge Health reports fourth quarter and full year 2025 financial results San Francisco, California - February 10, 2026 - Hinge Health, Inc. (NYSE: HNGE) today announced record financial results for the quarter and year ended December 31, 2025. “We closed out the year with an exceptional quarter and a strong selling season, driving our highest win rates to date and greatest number of eligible lives added in any year,” said Dan…
Read attachment ↗hnge-ex99_1.htm · 8-K · 2025-11-12
EX-99.1 2 hnge-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Hinge Health announces $250 million share repurchase program San Francisco, California - November 12, 2025 - Hinge Health, Inc. (NYSE: HNGE) today announced that its board of directors has authorized a $250 million share repurchase program. “During the first three quarters of 2025, we generated $108 million in cash from operations and $118 million in free cash flow1, reflecting the strength and scalability of our business model,” sai…
Read attachment ↗